NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.00654.c: Acetyl-CoA acetyltransferase

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: crystallized
center reference id: MysmA.00654.c
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.00654.c.A1.PS00605 Full length( MysmA.00654.c ) 1 387

External Resources

Resource Reference ID
OrthoMCL: NO_GROUP
PATRIC ID: fig|246196.19.peg.5832
RefSeq: YP_890222.1
UniProt: A0R4Y4

Enzyme & Pathway Information

Pathway Pathway ID EC Number
pyruvate fermentation to butanoate CENTFERM-PWY 2.3.1.16
superpathway of ergosterol biosynthesis I ERGOSTEROL-SYN-PWY 2.3.1.16
fatty acid beta-oxidation I FAO-PWY 2.3.1.16
L-glutamate degradation VII (to butanoate) GLUDEG-II-PWY 2.3.1.16
L-isoleucine degradation I ILEUDEG-PWY 2.3.1.16
L-glutamate degradation V (via hydroxyglutarate) P162-PWY 2.3.1.16
L-lysine fermentation to acetate and butanoate P163-PWY 2.3.1.16
polyhydroxybutanoate biosynthesis PWY1-3 2.3.1.16
fermentation to 2-methylbutanoate PWY-5109 2.3.1.16
fatty acid beta-oxidation II (peroxisome) PWY-5136 2.3.1.16
glutaryl-CoA degradation PWY-5177 2.3.1.16
toluene degradation VI (anaerobic) PWY-5184 2.3.1.16
superpathway of L-lysine degradation PWY-5327 2.3.1.16
superpathway of glyoxylate cycle and fatty acid degradation PWY-561 2.3.1.16
acetyl-CoA fermentation to butanoate II PWY-5676 2.3.1.16
ethylmalonyl-CoA pathway PWY-5741 2.3.1.16
3-hydroxypropanoate/4-hydroxybutanate cycle PWY-5789 2.3.1.16
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) PWY-5910 2.3.1.16
Methanobacterium thermoautotrophicum biosynthetic metabolism PWY-6146 2.3.1.16
mevalonate pathway II (archaea) PWY-6174 2.3.1.16
4-hydroxybenzoate biosynthesis III (plants) PWY-6435 2.3.1.16
pyruvate fermentation to butanol I PWY-6583 2.3.1.16
pyruvate fermentation to acetone PWY-6588 2.3.1.16
superpathway of Clostridium acetobutylicum acidogenic fermentation PWY-6590 2.3.1.16
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 2.3.1.16
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 2.3.1.16
ketogenesis PWY66-367 2.3.1.16
ketolysis PWY66-368 2.3.1.16
fatty acid beta-oxidation VI (peroxisome) PWY66-391 2.3.1.16
superpathway of cholesterol biosynthesis PWY66-5 2.3.1.16
pyruvate fermentation to hexanol (engineered) PWY-6863 2.3.1.16
isopropanol biosynthesis (engineered) PWY-6876 2.3.1.16
pyruvate fermentation to butanol II (engineered) PWY-6883 2.3.1.16
1-butanol autotrophic biosynthesis (engineered) PWY-6886 2.3.1.16
superpathway of cholesterol degradation I (cholesterol oxidase) PWY-6928 2.3.1.16
superpathway of testosterone and androsterone degradation PWY-6937 2.3.1.16
androstenedione degradation PWY-6944 2.3.1.16
cholesterol degradation to androstenedione I (cholesterol oxidase) PWY-6945 2.3.1.16
cholesterol degradation to androstenedione II (cholesterol dehydrogenase) PWY-6946 2.3.1.16
superpathway of cholesterol degradation II (cholesterol dehydrogenase) PWY-6947 2.3.1.16
sitosterol degradation to androstenedione PWY-6948 2.3.1.16
glycerol degradation to butanol PWY-7003 2.3.1.16
fatty acid salvage PWY-7094 2.3.1.16
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered) PWY-7216 2.3.1.16
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) PWY-7218 2.3.1.16
fatty acid beta-oxidation (peroxisome, yeast) PWY-7288 2.3.1.16
10-cis-heptadecenoyl-CoA degradation (yeast) PWY-7337 2.3.1.16
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast) PWY-7338 2.3.1.16
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast) PWY-7339 2.3.1.16
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast) PWY-7340 2.3.1.16
jasmonic acid biosynthesis PWY-735 2.3.1.16
isoprene biosynthesis II (engineered) PWY-7391 2.3.1.16
crotonate fermentation (to acetate and cyclohexane carboxylate) PWY-7401 2.3.1.16
benzoate fermentation (to acetate and cyclohexane carboxylate) PWY-7402 2.3.1.16
mevalonate pathway III (archaea) PWY-7524 2.3.1.16
docosahexaenoate biosynthesis III (6-desaturase, mammals) PWY-7606 2.3.1.16
(8E,10E)-dodeca-8,10-dienol biosynthesis PWY-7654 2.3.1.16
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase) PWY-7726 2.3.1.16
2-methylpropene degradation PWY-7778 2.3.1.16
methyl tert-butyl ether degradation PWY-7779 2.3.1.16
4-oxopentanoate degradation PWY-7948 2.3.1.16
mevalonate pathway I PWY-922 2.3.1.16
L-tryptophan degradation III (eukaryotic) TRYPTOPHAN-DEGRADATION-1 2.3.1.16
acetoacetate degradation (to acetyl CoA) ACETOACETATE-DEG-PWY 2.3.1.9

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MGNPVIVEAT RSPIGKRNGW LSGLHATELL GAVQKALVEK AGIDPGSVEQ IIGGCVTQYG EQSNNITRVG WLTAGLPEHV GATTIDCQCG SAQQANHLVA GLIATGAIDI GIACGIEAMS RVGLGANAGP DRSLIRASSW DIDMPNQFEA AERIAQRRGI TRADVDALGL ASQRKAKQAW DEGRFDREIS PISAPVLDEN KQPTSEWAPV TRDQGLRDTT PEALASLKPV LDGGIHTAGT SSQISDGAAA VLWMDEDKAK ALGLKPRARI VAQANVGAET YYHLDGPVQS TARVLEKAGM KLGDIDLVEI NEAFASVVLS WAQVHNADMD KVNVNGGAIA LGHPVGSTGA RLITTALHEL ERTGKGTALI TMCAGGALST GTIIERI

NT Sequence
ATGGGTAATC CTGTCATCGT CGAAGCCACC CGTAGCCCGA TCGGAAAACG CAACGGGTGG TTGTCCGGTC TGCACGCCAC GGAACTGCTG GGTGCGGTGC AGAAGGCGCT GGTGGAGAAG GCTGGCATCG ACCCCGGATC CGTCGAGCAG ATCATCGGTG GCTGCGTCAC CCAGTACGGC GAGCAGTCCA ACAACATCAC CCGCGTGGGG TGGCTGACCG CGGGATTGCC CGAGCACGTC GGCGCCACCA CCATCGACTG CCAGTGCGGC AGCGCGCAGC AGGCCAACCA TCTGGTGGCC GGCCTGATCG CGACGGGTGC GATCGACATC GGCATCGCGT GCGGTATCGA GGCCATGAGC CGCGTGGGCC TGGGCGCCAA CGCGGGCCCG GACCGTTCGC TGATCCGCGC GTCGTCGTGG GACATCGACA TGCCCAACCA GTTCGAGGCG GCCGAACGGA TCGCCCAGCG CCGCGGCATC ACGCGTGCCG ACGTCGACGC CCTCGGCCTG GCGTCGCAGC GCAAGGCCAA GCAGGCCTGG GACGAAGGCC GGTTCGACCG CGAGATCTCC CCCATCTCGG CCCCGGTGCT CGACGAGAAC AAGCAGCCCA CGTCGGAATG GGCTCCCGTC ACGCGCGACC AGGGTCTGCG TGACACCACA CCCGAAGCGC TGGCGTCGCT CAAGCCCGTG CTGGACGGCG GCATCCACAC CGCGGGAACG TCGTCGCAGA TCTCCGACGG CGCGGCCGCG GTGCTGTGGA TGGACGAGGA CAAGGCCAAG GCGCTCGGCC TCAAGCCGCG GGCGCGCATC GTCGCGCAGG CCAACGTCGG CGCCGAGACC TACTACCACC TCGACGGCCC GGTGCAGTCC ACCGCGCGGG TGCTGGAGAA GGCGGGCATG AAGCTCGGCG ACATCGACCT CGTCGAGATC AACGAGGCCT TCGCGTCGGT CGTGCTGTCG TGGGCACAGG TGCACAATGC CGACATGGAC AAGGTGAACG TCAACGGCGG CGCGATCGCG CTGGGCCACC CGGTCGGATC GACCGGCGCC CGCCTGATCA CCACGGCACT GCACGAACTG GAGCGCACCG GCAAGGGCAC CGCGCTCATC ACGATGTGCG CCGGCGGGGC GCTGTCCACG GGCACCATCA TCGAGCGCAT C

© 2020 Seattle Children's Research Institute. All rights reserved.